Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Notice of Intent to Sole Source to Quality Control for Molecular Diagnostics

Active
000HCJDB-2026-96903Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Centers for Disease Control and Prevention (CDC) plans to award a sole source purchase order to Quality Control for Molecular Diagnostics (QCMD) for Customized Proficiency Testing (PT) Panel Services, specifically supporting enterovirus proficiency panels. QCMD will manage the preparation, distribution, and data collection for these panels, which are essential for external laboratories conducting enterovirus testing to demonstrate proficiency under a CDC-approved program. QCMD is uniquely qualified as the sole provider specializing in External Quality Assessment (EQA) and Proficiency Testing schemes that comply with the necessary regulations, making them the only responsible source able to meet the government's requirements. Although this notice announces the intended sole source procurement, the CDC invites interested parties to express their interest or submit proposals within ten days of the notice issuance, by 11:00 a.m. EDT on June 22, 2026. This solicitation is not a formal request for competitive quotes but serves to determine whether a competitive procurement should be pursued. The contract will be administered by the CDC Office of Acquisition Services, with performance located in Glasgow, Scotland, and no set-aside designation applies. The primary point of contact for this procurement is Tiesha Brown, reachable by email at xrm5@cdc.gov.

General Info

CDC intends sole source award to QCMD for enterovirus proficiency testing panel services.

Agency

Department Of Health And Human Services → CDC Office Of Acquisition Services

NAICS

334516 - Analytical Laboratory Instrument Manufacturing View NAICS

Place of Performance

Glasgow, GB-SCT, G20 0XA, GBR

Set-Aside

NONE

Documents

(1)

CDC Notice of Intent to Sole Source to QCMD for Proficiency Testing Services

DOCXsources-sought

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhasePresolicitation
Posted

Presolicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → CDC Office Of Acquisition Services
Contacts2 people available
OfficeATLANTA, GA, 30333, USA
Organization / Agency
Department Of Health And Human Services → CDC Office Of Acquisition Services
Office AddressATLANTA, GA, 30333, USA

Full Description

Show more

The Centers for Disease Control and Prevention (CDC) intends to award a sole source purchase order to American Association for Laboratory Accreditation for services for which the Government intends to solicit and negotiate with only one source under the authority of 12.102(a) (FAR -RFO) and 41 U.S.C.3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.


Contractor: Quality Control for Molecular Diagnostics (QCMD)


Description of product/service: Customized Proficiency Testing (PT) Panel Services


Capability: The vendor shall provide support for enterovirus proficient panels, including preparation, distribution, and data collection. External laboratories that conduct enterovirus testing must demonstrate proficiency by participating in a CDC approved PT scheme. QCMD is the only vendor that specializes in the provision and management of External Quality Assessment (EQA)/PT schemes in accordance with relevant regulations. Therefore, QCMD is the only responsible source capable of meeting the Government’s requirement.


This notice of intent is not a request for competitive quotations; however, all quotations/responses received within ten (10) days of the issuance of this notice will be considered by the government.  A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.  Information received will normally be considered solely for the purpose of determining whether to conduct competitive procurement.  Any quotation/response should be emailed to contract specialist at xrm5@cdc.gov by 11:00 a.m. EDT on 22 June 2026.

Similar Contracts

NAICS: 334516
New
Federal
FDA-RFQ- BioProfile FLEX2 Parts and Components-Brand Name or EqualThe contract solicitation seeks quotations for supplying parts and components compatible with three Nova BioProfile FLEX 2 instruments owned by the FDA’s Center for Drug Evaluation and Research (CDER). The requirement includes parts for two main FLEX2 instruments and an additional external sampling module, each identified by specific serial numbers. The contractor must provide new, unused, and defect-free commercial parts or equivalent consumables that fully function with the instruments in their current configuration, without requiring modifications. Delivered items must maintain at least 75% to 80% of their shelf life, and those requiring special conditions such as refrigeration or flammable item handling must comply with relevant regulations. Only manufacturers or authorized resellers may submit quotes, which are due via email by June 26, 2026. The contract period covers 12 consecutive months from the award date, with performance based at the FDA facility in Silver Spring, Maryland. The procurement process is issued as a combined synopsis/solicitation under commercial item acquisition rules, with no separate solicitation document forthcoming. The solicitation emphasizes strict adherence to delivery schedules and quality standards detailed in the attached Statement of Work. Communication and submission of quotations are managed through the designated FDA point of contact.
FDA Office Of Acq Grant Svcs

POSTED

1 day ago

DEADLINE

in 10 days
View Details
NAICS: 334516
New
Federal
Protective Clothing Blood Penetration Resistance TesterThe U.S. Food and Drug Administration’s Center for Devices and Radiological Health is conducting a market research effort to identify small businesses capable of supplying a Protective Clothing Blood Penetration Resistance Tester. This device is intended to automate and improve the testing of level 4 medical gowns for viral penetration resistance, significantly reducing manual testing time while enhancing consistency and repeatability. The instrument must meet several technical specifications, including the ability to run four simultaneous tests, automatic timing functions, real-time pressure monitoring, and compliance with ASTM F1670 and ASTM F1671 standards. The system must be new, turn-key, and include all necessary hardware, software, manuals, installation, training, and qualification documentation. Interested firms, particularly small businesses under NAICS code 334516, are invited to submit capability statements by June 23, 2026. Responses should include detailed company information, past performance data, technical compliance evidence, warranty terms, and manufacturing origin to facilitate evaluation under Buy American requirements. The delivery location is the FDA’s Winchester Engineering and Analytical Center in Massachusetts, with delivery expected within 120 days of award. This announcement does not constitute a solicitation or binding contract but serves as an information-gathering step for potential future procurements.
FDA Office Of Acq Grant Svcs

POSTED

1 day ago

DEADLINE

in 7 days
View Details